Design and setting
This is a cross-sectional study of pediatric patients who have experienced COVID-19 infection in the past 1-6 months. The study was undertaken from July 2021 to February 2023. This research was approved by the ethic committee (IRB No. 851/64). Informed consent was obtained from the parents of patients before proceeding the study.